Asepxia Softening Acne Bar

Description

Asepxia Acne Bar Soap is formulated with 2% salicylic acid and enriched with cucumber extract. This product is designed for deep cleansing and moisturizing, effectively removing dirt, oil, bacteria, and dead skin cells. The soap provides a soft and fresh feel to the skin. Each bar has a net weight of 4 oz (113 g) and features the proprietary Hydro-Force technology.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively reduces the number of acne pimples and allows the skin to heal. The formulation penetrates pores to clear most acne blemishes and dries up existing acne pimples. Additionally, it helps maintain clear skin by preventing the formation of new acne blemishes, including whiteheads and blackheads.

No teratogenic or nonteratogenic effects have been mentioned.

Dosage and Administration

Healthcare professionals are advised to apply the product liberally over wet skin using a clean washcloth or body puff, with particular focus on areas prone to acne. Following application, the product should be rinsed thoroughly from the skin and the area patted dry with a clean towel.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to every other day to mitigate these effects.

Contraindications

Use of this product is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion or misuse.

• If excessive skin irritation occurs, discontinue use and consult a healthcare professional.

• Contact with the eyes should be avoided. In the event of contact, rinse thoroughly with water.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that skin irritation and dryness may occur if this product is used concurrently with other topical acne medications or immediately following their application. In such cases, it is recommended to use only one medication at a time unless otherwise directed by a healthcare provider.

Patients should be cautioned to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is imperative to rinse thoroughly with water.

If excessive skin irritation occurs, patients should discontinue use and consult a healthcare professional for further guidance.

Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients using this product should be aware that it is for external use only. During treatment, skin irritation and dryness may occur, particularly if other topical acne medications are used concurrently or immediately following the application of this product. In such cases, it is advised to use only one medication at a time unless directed by a healthcare professional.

Patients should avoid contact with the eyes; if the product inadvertently comes into contact with the eyes, it is important to rinse thoroughly with water.

In the event of excessive skin irritation, patients are advised to discontinue use and consult a doctor. Additionally, this product should be kept out of reach of children. If swallowed, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

Concurrent use of this product with other topical acne medications may lead to skin irritation and dryness. It is advisable to apply only one topical acne treatment at a time to minimize the risk of adverse effects, unless otherwise directed by a healthcare professional. Monitoring for signs of skin irritation is recommended, and dosage adjustments should be considered based on the severity of any adverse reactions.

Packaging & NDC

Below are the non-prescription pack sizes of Asepxia Softening Acne Bar (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. Safety and efficacy in pediatric populations have not been established, and specific dosing recommendations for children are not provided. Caution is advised when administering this medication to ensure it is not accessible to young children.

Geriatric Use

There is no specific information regarding the use of Asepxia Softening Acne Bar Soap in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise clinical judgment when considering the use of this product in the geriatric population, as individual patient factors may influence safety and efficacy. Monitoring for any adverse effects is advisable when this product is used in elderly patients.

Pregnancy

There is no specific information regarding the use of Asepxia Softening Acne Bar Soap during pregnancy. The drug insert does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when recommending this product to women of childbearing potential and consider the lack of data on potential fetal impacts. It is advisable to weigh the benefits against any unknown risks when considering the use of this product in pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there are no specific considerations or precautions mentioned regarding lactation or the potential for excretion in breast milk.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if they experience excessive skin irritation. It is important to discuss that while using this product, skin irritation and dryness may occur, particularly if they are using other topical acne medications concurrently or immediately after applying this product. Patients should be instructed to use only one medication at a time unless otherwise directed by a healthcare professional.

Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes. If the product inadvertently gets into the eyes, patients should rinse thoroughly with water.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers assigned for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

Patients should apply the product liberally over wet skin using a clean wash cloth or body puff, focusing on areas that are prone to acne. After application, it is important to rinse thoroughly and pat dry with a clean towel. In cases where bothersome dryness or peeling occurs, patients are advised to reduce the frequency of application to every other day.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Asepxia Softening Acne Bar, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)